All In Biotech

Drug Trial Radar · NCT00625365

A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

Last checked: Nov 20, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

1,060

Actual

Start

Feb 2008

Primary completion

May 2009

Study completion Jul 2009

Sponsor

Lead sponsor
Lantheus Medical ImagingIndustry
Sponsor type
Industry
First posted
Feb 28, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®

Conditions

  • Cardiovascular Disease

Interventions

  • DEFINITY®Drug

    DEFINITY may be injected by either an intravenous or bolus injection or infusion. Dosage as per standard clinical practice and Package Insert

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Number and Percentage of Patients With Death or Life Threatening Cardiopulmonary Events Occurring Following Definity AdministrationTime frame: during or within 30 minutes of administration

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • UCSD Medical Center

    San Diego, California

  • Alfieri Cardiology

    Newark, Delaware

  • Northwestern University

    Chicago, Illinois

  • Maine Research Associates

    Auburn, Maine

  • Park Nicolett Institute

    Saint Louis Park, Minnesota

  • Cardiovascular Consultants, P.C.

    Kansas City, Missouri

  • St. Louis University

    St Louis, Missouri

  • St. Luke's-Roosevelt Hospital

    New York, New York

  • Mt Sinai Medical Center

    New York, New York

  • Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina

  • Meritcare Heart Center Cardiology

    Fargo, North Dakota

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

  • York Hospital

    York, Pennsylvania

  • Consultants in Cardiology

    Fort Worth, Texas

  • University of Texas Medical Center

    Galveston, Texas

  • The Methodist DeBakey Heart Center

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.